The Mercury : Mobile & Gadgets http://business-news.thestreet.com/the-mercury en urn:article:12779775 Facebook Q2 Earnings Live Blog Recap http://business-news.thestreet.com/the-mercury/story/facebook-q2-earnings-live-blog-recap/12779775 Live Blog Facebook Q2 Live Blog   NEW YORK (TheStreet) –– Facebook earnings blew past Wall Street estimates, as the social network continues… Wed, 23 Jul 2014 18:08:00 EDT http://www.thestreet.com/story/12783757/1/gilead-sovaldi-35-billion-the-most-important-number-in-biotech-earnings-season.html Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season http://business-news.thestreet.com/the-mercury/story/gilead-sovaldi-35-billion-the-most-important-number-biotech-earnings-season-0/1 Updated with new information following Gilead's conference call: Gilead Sciences just reported second-quarter Sovaldi sales of $3.48 billion, a tad short of the buyside investor "whisper… Wed, 23 Jul 2014 17:44:00 EDT http://www.thestreet.com/story/12784127/1/the-curious-case-of-william-ackman.html The Curious Case of William Ackman http://business-news.thestreet.com/the-mercury/story/the-curious-case-william-ackman/1 Jack Mohr (The Street) -- In ancient Greek mythology, a character possessed Hubris if he convinced himself he could be equal to the gods. In… Wed, 23 Jul 2014 17:08:00 EDT urn:article:12782015 Why Facebook Shares Are Surging http://business-news.thestreet.com/the-mercury/story/why-facebook-shares-are-surging/12782015 NEW YORK (TheStreet) –– Facebook   shares were surging 4.2% to $74.29 in after-hours trading following better-than-expected quarterly results led by strong mobile advertising revenue growth. Facebook… Wed, 23 Jul 2014 16:56:00 EDT urn:article:12783505 Retail Report Card: Sales Growth Is Resilient for the Second Half http://business-news.thestreet.com/the-mercury/story/retail-report-card-sales-growth-is-resilient-for-the-second-half/12783505 NEW YORK (TheStreet) -- Despite the outlook from economists stating retail growth is faced with challenges the remainder of this year, retail sales growth will… Wed, 23 Jul 2014 14:58:00 EDT urn:article:12783515 An iPhone 6 With a Sapphire Display Would Change Everything http://business-news.thestreet.com/the-mercury/story/an-iphone-6-with-a-sapphire-display-would-change-everything/12783515 NEW YORK (TheStreet) -- Apple has locked up a big part of the world's sapphire production capacity. Apple customers have a special appreciation for… Wed, 23 Jul 2014 14:49:00 EDT urn:article:12783467 Apple, Microsoft Earnings Solid: Tech Winners & Losers http://business-news.thestreet.com/the-mercury/story/apple-microsoft-earnings-solid-tech-winners-losers/12783467 NEW YORK (TheStreet) ––Apple shares jumped 3% to $97.56 after reporting solid third quarter earnings yesterday afternoon. Apple earned $1.28 a share on revenue… Wed, 23 Jul 2014 12:41:00 EDT urn:article:12783319 Are Consumers Losing Interest In Tablets? http://business-news.thestreet.com/the-mercury/story/are-consumers-losing-interest-in-tablets/12783319 NEW YORK (TheStreet) -- Tablets had historically been a very hard sell for computer manufacturers until Apple's  introduction of the iPad changed consumers' priorities. But recently… Wed, 23 Jul 2014 12:27:00 EDT http://www.thestreet.com/story/12783508/1/puma-shares-soar-when-wall-street-misplays-expectation-game.html Puma Shares Soar When Wall Street Misplays Expectation Game http://business-news.thestreet.com/the-mercury/story/puma-shares-soar-when-wall-street-misplays-expectation-game/1 The reason Puma Biotechnology is up a jaw-dropping 287% Wednesday is because the stock was relatively under-owned (not heavily shorted) by healthcare investors. That… Wed, 23 Jul 2014 12:26:00 EDT http://www.thestreet.com/story/12783203/1/inovio-declares-spin-laden-victory-with-dna-vaccine.html Inovio Declares Spin-Laden Victory With DNA Vaccine http://business-news.thestreet.com/the-mercury/story/inovio-declares-spin-laden-victory-dna-vaccine/1 Updated from 10:17 am EDT with new information. Inovio Pharmaceuticals declared a spin-laden victory Wednesday from its phase II study of the DNA vaccine VGX-3100 in… Wed, 23 Jul 2014 10:17:00 EDT